ollowing yesterday’s positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 vaccine, the U.S. Food and Drug Administration (FDA) has informed the sponsor that it will rapidly work toward finalization and issuance of an Emergency Use Authorization (EUA). Read more...
Sanofi and GSK have announced a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in older adults. Read more...
Kantaro Biosciences, a joint venture between the Mount Sinai Health System and RenalytixAI, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for COVID-SeroKlir, its semi-quantitative SARS-CoV-2 IgG antibody test kit. Read more...
Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.